Ultrafiltration (UF) Effectiveness on intradialytic hypertension (IDH)

Ultrafiltration (UF) Effectiveness on intradialytic hypertension (IDH) in chronic hemodialysed patients in a nephrology unit in Dakar: UF-IDH clinical trial.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202001714181321

Enrollment

Registered

2020-01-15

Start date

2018-09-10

Completion date

Unknown

Last updated

2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Disease

Interventions

Ultrafiltration

control

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All chronic hemodialysed patients (for more than 3 months) in Aristide Le Dantec hemodialysis units, undergoing IDH, aged at least 18 years and consenting to the study were included.

Exclusion criteria

Exclusion criteria: Missing 3 sessions out of the last 6 before randomization; a clinical volume overload; clinical dehydration; intolerance to UF; severe cardiovascular comorbidities (stroke, ischemic heart disease, severe lower limbs obliterating arteriopathy (LLOA) or left ventricular ejection fraction (LVEF) less than 50%); deciding to not participate in the study; chronic hypotension.

Design outcomes

Primary

Measure	Time frame
Progressive UF was associated with a significant reduction in the prevalence of IDH in our patients at week 4.	—

Secondary

Measure	Time frame
ultrafiltration was not always well tolerated.	—

Countries

Senegal

Contacts

Public ContactMoustapha Faye

Nephrology department

mfayeintaida@gmail.com+221772596225

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026